
New Research on Black Seed Oil Examines the Link Between Gut Bacteria and the Stress Response
Key Takeaways
- TriNutra’s multi-study package associates ThymoQuin 500 mg daily with cortisol lowering, improved DHEA:cortisol balance, sleep-quality gains, and signals across immune, metabolic, and cardiovascular measures.
- An in vitro gut microbiota model showed selective, concentration-dependent shifts: marked Streptococcus thermophilus expansion, preservation of Lactiplantibacillus plantarum and Akkermansia muciniphila, and >94% inhibition of Klebsiella pneumoniae.
TriNutra is presenting new data on its standardized black seed oil ingredient at SupplySide Global, adding to a growing body of research on how gut bacteria and the body's stress response may influence each other.
TriNutra, a supplier of standardized black seed oil ingredients, is using SupplySide Global 2026 to present what it describes as a more complete picture of the relationship between gut bacteria and the body's stress response, built around its ingredient ThymoQuin.
The company has been studying the ingredient, standardized to at least 3% thymoquinone, across several small clinical and laboratory investigations examining stress, sleep, mood, and microbiome markers.¹
"What is exciting about this research is that we are beginning to see a more complete picture of how the gut and the body's response to stress may be connected," said Morris Zelkha, CEO of TriNutra. "Each study adds another piece to that picture and gives us new areas to investigate. We plan to continue investing and expanding the science behind ThymoQuin and its adaptogenic resilience, microbiome recalibration, and its proven long-term safety, which we are referring to as the Gut-Stress-Axis."
What New Research Is TriNutra Presenting on the Gut-Stress Axis?
The company points to 4 clinical and laboratory investigations examining ThymoQuin's effects across stress, cortisol, sleep, mood, immune, metabolic, cardiovascular, and microbiome outcomes.¹
Newly reported figures include cortisol reductions ranging from 23% to 44%, a 29% improvement in the ratio of dehydroepiandrosterone to cortisol, a 31% improvement in sleep quality, and a 66% increase in Streptococcus thermophilus, alongside earlier findings on blood pressure, gut microbiome composition, cortisol, and mood.¹
TriNutra attributes these effects to a single 500 mg daily dose and describes the ingredient as formulated to meet United States Pharmacopeia monograph standards for identity and purity.
How Does the Ingredient Appear to Affect Gut Bacteria?
The most detailed new data comes from an in vitro laboratory study, now posted as a bioRxiv preprint, examining ThymoQuin's effect on gut bacteria across 3 independent batches.²
Within an intermediate concentration range, the ingredient increased growth of Streptococcus thermophilus by as much as 53-fold, preserved Lactiplantibacillus plantarum and Akkermansia muciniphila, and inhibited Klebsiella pneumoniae by more than 94%.¹,² The preprint notes that this selectivity was concentration-dependent: at the lowest concentrations tested, effects on some organisms were minimal, and at the highest concentration, the ingredient's antimicrobial activity became broader and less selective, affecting beneficial and non-beneficial bacteria alike.²
TriNutra describes the narrower, selective range as a hormetic window associated with its recommended 500 mg daily dose, though the preprint itself is an in vitro model and does not establish how closely laboratory concentrations correspond to conditions in the human gut.
What Should Manufacturers Weigh Before Relying on This Data?
The research sits within a broader, still-developing literature on standardized black seed oil extracts and stress physiology; a separate, differently formulated black cumin oil extract was shown in a 2023 randomized, placebo-controlled trial to reduce stress and improve sleep without adverse effects, suggesting the ingredient class has drawn independent research interest beyond this company's own program.³
The in vitro design also cannot speak to clinical outcomes on its own, and the company's own data show that the favorable microbial selectivity it highlights was dose- and concentration-dependent rather than uniform.² Manufacturers evaluating the ingredient for stress- or gut-related product claims will want to see the completed peer-reviewed publication and independent replication before treating the current figures as settled.
References
1. TriNutra. TriNutra to showcase new research examining the gut-stress axis and ThymoQuin at SupplySide Global. October 5, 2026. Accessed October 5, 2026. Press release provided via email.
2. Papini FS, Zettner N, Sawas S, Roth C, Bäumer L. Less is more: hormetic and selective antimicrobial activity of a thymoquinone-standardized black seed oil ThymoQuin in gut microbiota models. bioRxiv. May 10, 2026. doi:10.64898/2026.05.10.724082
3. Mohan ME, Thomas JV, Mohan MC, Das S S, Prabhakaran P, Chakrapani PulikkaparambilSasidharan B. A proprietary black cumin oil extract (Nigella sativa) (BlaQmax) modulates stress-sleep-immunity axis safely: randomized double-blind placebo-controlled study. Front Nutr. 2023;10:1152680. doi:10.3389/fnut.2023.1152680
Related to this article









